High blood pressure can cause kidney damage, which can increase blood pressure, leading to a vicious cycle. It is not clear whether the protective effects of T-type calcium channel blockers (T-type CCBs) on renal function are better than those of L-type CCBs or renin-angiotensin system (RAS) antagonists in patients with hypertension.24.09, p = 0.0005); no significant difference was noted for systolic blood pressure (SBP) (p = 0.76) and diastolic blood pressure (DBP) (p = 0.16). The effects of T-type CCBs did not significantly differ from those of RAS antagonists for SBP (p = 0.98), DBP (p = 0.86), glomerular filtration rate (p = 0.93), albuminuria (p = 0.97), creatinine clearance rate (p = 0.24), and serum creatinine (p = 0.27) in patients ...
Background: Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in ...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...
High blood pressure can cause kidney damage, which can increase blood pressure, leading to a vicious...
<div><p>Background</p><p>High blood pressure can cause kidney damage, which can increase blood press...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further progre...
Beside effective systemic blood pressure control, calcium channel blockers exert several effects on ...
Beside effective systemic blood pressure control, calcium channel blockers exert several effects on ...
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabol...
Background: Hypertension and proteinuria are critically involved in the progression of chronic kidne...
textabstractBackground: Hypertension and proteinuria are critically involved in the progression of c...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Antihypertensive treatment of patients with proteinuric renal diseases: Risks or benefits of calcium...
Background: Hypertension and proteinuria are critically involved in the progression of chronic kidne...
Background: Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in ...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...
High blood pressure can cause kidney damage, which can increase blood pressure, leading to a vicious...
<div><p>Background</p><p>High blood pressure can cause kidney damage, which can increase blood press...
Background: Decline in estimated Glomerular filtration rate (eGFR) is associated with further progre...
Beside effective systemic blood pressure control, calcium channel blockers exert several effects on ...
Beside effective systemic blood pressure control, calcium channel blockers exert several effects on ...
The advancing chronic renal failure is at most the consequence of secondary haemodynamic and metabol...
Background: Hypertension and proteinuria are critically involved in the progression of chronic kidne...
textabstractBackground: Hypertension and proteinuria are critically involved in the progression of c...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Hypertension and high levels of proteinuria are independent risk factors for accelerated progression...
Antihypertensive treatment of patients with proteinuric renal diseases: Risks or benefits of calcium...
Background: Hypertension and proteinuria are critically involved in the progression of chronic kidne...
Background: Renin-angiotensin system inhibitor and calcium channel blocker (CCB) are widely used in ...
Effective treatment of high blood pressure (BP) represents a key strategy for reducing the burden of...
ABSTRACT. CALCIUM ANTAGONISTS are first-line antihypertensive agents but their effects in patients w...